Laura Comerma

5.0k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Laura Comerma is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura Comerma has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura Comerma's work include Cancer Immunotherapy and Biomarkers (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Cells and Metastasis (3 papers). Laura Comerma is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Cells and Metastasis (3 papers). Laura Comerma collaborates with scholars based in Spain, United States and United Kingdom. Laura Comerma's co-authors include Andrea Cerutti, Linda Cassis, Montserrat Cols, Maurizio Gentile, J. Magarian Blander, Anna Bigas, Leonard H. Augenlicht, Kang Chen, A. Walland and Huabao Xiong and has published in prestigious journals such as Science, Nature Immunology and Gastroenterology.

In The Last Decade

Laura Comerma

16 papers receiving 1.1k citations

Hit Papers

Mucus Enhances Gut Homeostasis and Oral Tolerance by Deli... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Comerma Spain 10 526 384 346 201 146 17 1.1k
Michail Schizas United States 16 623 1.2× 531 1.4× 361 1.0× 142 0.7× 70 0.5× 17 1.4k
Lukas F. Mager Canada 9 513 1.0× 773 2.0× 547 1.6× 201 1.0× 79 0.5× 15 1.5k
Samuel McGee United States 14 524 1.0× 795 2.1× 302 0.9× 286 1.4× 63 0.4× 19 1.5k
Toshifumi Ohkusa Japan 23 494 0.9× 703 1.8× 501 1.4× 222 1.1× 65 0.4× 54 1.5k
Anna Vossenkämper United Kingdom 20 494 0.9× 473 1.2× 113 0.3× 123 0.6× 89 0.6× 28 1.2k
Gady Cojocaru United States 10 412 0.8× 725 1.9× 161 0.5× 133 0.7× 61 0.4× 22 1.3k
Michal Tomczak United States 13 865 1.6× 320 0.8× 541 1.6× 302 1.5× 93 0.6× 15 1.6k
Hilde Schjerven United States 20 672 1.3× 536 1.4× 183 0.5× 79 0.4× 55 0.4× 29 1.4k
Marie Vétizou France 11 726 1.4× 720 1.9× 869 2.5× 73 0.4× 187 1.3× 20 1.6k
Masumi Shimizu Japan 19 785 1.5× 368 1.0× 368 1.1× 152 0.8× 59 0.4× 71 1.5k

Countries citing papers authored by Laura Comerma

Since Specialization
Citations

This map shows the geographic impact of Laura Comerma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Comerma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Comerma more than expected).

Fields of papers citing papers by Laura Comerma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Comerma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Comerma. The network helps show where Laura Comerma may publish in the future.

Co-authorship network of co-authors of Laura Comerma

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Comerma. A scholar is included among the top collaborators of Laura Comerma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Comerma. Laura Comerma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Comerma, Laura, et al.. (2025). An update on multimodal imaging strategies for nipple discharge: from detection to decision. Insights into Imaging. 16(1). 70–70.
2.
Menéndez, Sílvia, David López, Beatríz Bellosillo, et al.. (2023). Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells. Human Pathology. 139. 91–105. 5 indexed citations
4.
Bellosillo, Beatríz, et al.. (2023). Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(5). 655–663. 1 indexed citations
5.
Posso, Margarita, Ivonne Vázquez, Laura Comerma, et al.. (2021). Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening. European Radiology. 32(1). 621–629. 13 indexed citations
6.
Peña, Raúl, et al.. (2021). Snail1 expression in endothelial cells controls growth, angiogenesis and differentiation of breast tumors. Theranostics. 11(16). 7671–7684. 10 indexed citations
7.
Peña, Raúl, José Rodríguez-Morató, Lorena Alba‐Castellón, et al.. (2020). Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion. Cancer Research. 81(2). 438–451. 52 indexed citations
8.
Louro, Javier, Marta Román, Margarita Posso, et al.. (2020). Differences in breast cancer risk after benign breast disease by type of screening diagnosis. The Breast. 54. 343–348. 12 indexed citations
9.
Martínez, Carlos, Laura Comerma, Ivonne Vázquez, et al.. (2020). Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice. Oncogene. 39(13). 2835–2843. 21 indexed citations
10.
Peg, Vicente, María Ángeles López‐García, Laura Comerma, et al.. (2020). Pd-L1 Testing Based on The SP142 Antibody in Metastatic Triple-Negative Breast Cancer: Summary of an Expert Round-Table Discussion. Future Oncology. 17(10). 1209–1218. 12 indexed citations
11.
Pijuán, Lara, Sergi Mojal, Marta Salido, et al.. (2019). Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy. Ultrastructural Pathology. 43(6). 237–247. 1 indexed citations
12.
Prat, Aleix, Alejandro Navarro, Laia Paré, et al.. (2017). Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma. Cancer Research. 77(13). 3540–3550. 277 indexed citations
13.
Magri, Giuliana, Michio Miyajima, Arthur Mortha, et al.. (2014). Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nature Immunology. 15(4). 354–364. 221 indexed citations
14.
Shan, Meimei, Maurizio Gentile, A. Walland, et al.. (2013). Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals. Science. 342(6157). 447–453. 473 indexed citations breakdown →
15.
He, Bin, et al.. (2013). Mucus Enhances Gut Homeostasis And Oral Tolerance By Delivering Immunoregulatory Signals. Zenodo (CERN European Organization for Nuclear Research). 9 indexed citations
16.
Castillo-Secilla, Daniel, Susana Puig, Mar Iglesias, et al.. (2011). Activation of the BMP4 Pathway and Early Expression of CDX2 Characterize Non-specialized Columnar Metaplasia in a Human Model of Barrett’s Esophagus. Journal of Gastrointestinal Surgery. 16(2). 227–237. 32 indexed citations
17.
Castillo-Secilla, Daniel, Susana Puig, Carme de Bolós, et al.. (2011). Activation of the BMP4 Pathway and Early Expression of CDX2 Characterize the Development of Nonspecialized Columnar Metaplasia in a Human Model of Barrett Esophagus. Gastroenterology. 140(5). S–1008. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026